Chinese herbal bath therapy for the treatment of Atopic dermatitis in children: A meta-analysis and systematic review

Medicine (Baltimore). 2022 Nov 25;101(47):e31923. doi: 10.1097/MD.0000000000031923.

Abstract

Background: To conduct a systematic review of the efficacy of Chinese herbal bath therapy on children with Atopic dermatitis.

Methods: We searched Chinese databases (CNKI, VIP, and Wanfang) and English databases (PubMed, Embase, Web of science, Cochrane library) for studies from the establishment of the database to September 2022. The included literature was randomized control studies investigating the treatment of Atopic dermatitis in children by Chinese herbal bath therapy. The outcomes included the cure rate, scoring atopic dermatitis (SCORAD) index, adverse reactions and recurrence rate. RevMan 5.4 was used to analyze the extracted data.

Results: A total of 8 related studies were included containing 854 cases. The meta-analysis showed that Chinese herbal bath therapy group was superior to control group in terms of cure rate, SCORAD index, adverse reactions and recurrence rate in children with Atopic dermatitis [RR = 1.11, 95%(1.02, 1.21), P = .01; SMD = -0.77, 95%(-0.99, -0.55), P < .00001; RR = 0.44, 95%CI(0.28,0.67), P = .0002; RR = 0.25, 95%CI(0.10, 0.59), P = .0002].

Conclusion: The present study shows that Chinese herbal bath therapy is an effective treatment for children with Atopic dermatitis in China.

Publication types

  • Systematic Review
  • Meta-Analysis

MeSH terms

  • Asian People
  • Child
  • China
  • Control Groups
  • Dermatitis, Atopic* / drug therapy
  • Humans
  • PubMed